On the other hand, cytokeratin 18 (CK-18) antibodies M65 and M30 may be better biomarkers of nonalcoholic steatohepatitis (NASH) than of advanced fibrosis (15). The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.